Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × pralsetinib × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Thyroid Neoplasms 1 Thoracic Neoplasms 1 Solid Tumors 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Neoplasms, Nerve Tissue 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Lung Neoplasms 1 Lung Diseases 1 Head and Neck Neoplasms 1 Carcinoma, Bronchogenic 1 Carcinoma 1 Bronchial Diseases 1 Adenocarcinoma 1

Interventions

atezolizumab 3 Etoposide 2 Cisplatin 2 zimberelimab 1 tivozanib 1 durvalumab 1 cabozantinib 1 belinostat 1 Temozolomide 1 Standard of Care 1 Positron Emission Tomography Computed Tomography 1 Nivolumab 1 Magnetic Resonance Imaging 1 Ipilimumab 1 Immunoglobulin G 1 Disulfides 1 Carboplatin 1 Capecitabine 1 CTLA-4 Antigen 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡